Elevated plasma levels of CXCL16 in severe COVID-19 patients

Genome-wide association studies have recently identified 3p21.31, with lead variant pointing to the CXCR6 gene, as the strongest thus far reported susceptibility risk locus for severe manifestation of COVID-19. In order the determine its role, we measured plasma levels of Chemokine (C‐X‐C motif) lig...

Descripción completa

Detalles Bibliográficos
Autores principales: Smieszek, Sandra P., Polymeropoulos, Vasilios M., Polymeropoulos, Christos M., Przychodzen, Bartlomiej P., Birznieks, Gunther, Polymeropoulos, Mihael H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801318/
https://www.ncbi.nlm.nih.gov/pubmed/35121493
http://dx.doi.org/10.1016/j.cyto.2022.155810

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801318/
https://www.ncbi.nlm.nih.gov/pubmed/35121493
http://dx.doi.org/10.1016/j.cyto.2022.155810

Ejemplares similares